Cytokines in Plasma and Ultrafiltrate during Continuous Arteriovenous Haemofiltration
Open Access
- 1 December 1993
- journal article
- research article
- Published by SAGE Publications in Anaesthesia and Intensive Care
- Vol. 21 (6) , 752-758
- https://doi.org/10.1177/0310057x9302100603
Abstract
Cytokines are considered to be important mediators in the pathophysiology of sepsis and septic shock. We investigated if continuous arteriovenous haemofiltration (CAVH) could be used to remove excessive amounts of the cytokines tumour necrosis factor-α (TNFα), interleukin (IL)-1α and IL-6 from peripheral blood in critically ill patients. Nine septic patients with renal failure were treated with CAVH. Ultrafiltrate and plasma were tested for cytokines by ELISA. All patients had detectable TNFα and IL-6 plasma levels, ranging from 10-750 pg/ml and 50-4,575 pg/ml, respectively. TNFα was removed by the ultrafiltrate with concentrations ranging from 10-1,000 pg/ml. The TNFα levels were significantly higher in the ultrafiltrate samples than in the corresponding plasma samples (P <0.003). IL-6 was undetectable in the ultrafiltrate from five of the patients despite concomitant high plasma levels. IL-1α was detectable in both plasma and ultrafiltrate in four patients. All patients developed multi-organ failure and septic shock and seven died. It is concluded that TNFα and IL-1α but not IL-6 can be removed by CAVH in patients with sepsis.Keywords
This publication has 22 references indexed in Scilit:
- Human anti-interleukin 1α antibodiesImmunology Letters, 1991
- Letʼs agree on terminologyCritical Care Medicine, 1991
- The haemodynamic effects of intermittent haemofiltration in critically ill patientsIntensive Care Medicine, 1991
- Hemofiltration Reverses Left Ventricular Dysfunction during Sepsis in DogsAnesthesiology, 1990
- Continuous Renal Replacement in the Critically IllAnaesthesia and Intensive Care, 1990
- Plasma Tumor Necrosis Factor in Patients with Septic Shock: Mortality Rate, Incidence of Adult Respiratory Distress Syndrome, and Effects of Methylprednisolone AdministrationAmerican Review of Respiratory Disease, 1989
- Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humansCritical Care Medicine, 1989
- Plasma tumor necrosis factor and mortality in critically ill septic patientsCritical Care Medicine, 1989
- Septic shock: the cardiovascular abnormality and therapyJournal of Cardiothoracic Anesthesia, 1989
- Interleukin 1, interleukin 6 and tumor necrosis factor in infection, inflammation and immunityImmunology Letters, 1988